Literature DB >> 26444403

Therapeutic Approaches to Inherited Optic Neuropathies.

Patrick Yu-Wai-Man1.   

Abstract

As a group, inherited optic neuropathies represent an important cause of severe irreversible visual loss among children and young adults. Leber hereditary optic neuropathy (LHON) and autosomal dominant optic atrophy (DOA) are the two most common forms encountered in clinical practice and several shared disease pathways have emerged that contribute to retinal ganglion cell loss, and eventually visual failure. In this review, the author critically appraises the evidence base for the various therapeutic strategies that have been put forward to treat these two mitochondrially determined optic neuropathies, including future developments. Innovative in vitro fertilization techniques to prevent female carriers of childbearing age from transmitting pathogenic mitochondrial DNA mutations to their biological children will also be discussed. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2015        PMID: 26444403     DOI: 10.1055/s-0035-1563574

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  9 in total

1.  Immune Response and Intraocular Inflammation in Patients With Leber Hereditary Optic Neuropathy Treated With Intravitreal Injection of Recombinant Adeno-Associated Virus 2 Carrying the ND4 Gene: A Secondary Analysis of a Phase 1/2 Clinical Trial.

Authors:  Céline Bouquet; Catherine Vignal Clermont; Anne Galy; Serge Fitoussi; Laure Blouin; Marion R Munk; Sonia Valero; Sandrine Meunier; Barrett Katz; José Alain Sahel; Nitza Thomasson
Journal:  JAMA Ophthalmol       Date:  2019-04-01       Impact factor: 7.389

2.  Whole Exome Sequencing Identifies Two Novel Mutations in the Reticulon 4-Interacting Protein 1 Gene in a Chinese Family with Autosomal Recessive Optic Neuropathies.

Authors:  Xiao-Huan Zou; Xin-Xin Guo; Hui-Zhen Su; Chong Wang; En-Lin Dong; Ning Wang; Wan-Jin Chen; Qi-Jie Zhang
Journal:  J Mol Neurosci       Date:  2019-05-10       Impact factor: 3.444

3.  The Natural History of Leber's Hereditary Optic Neuropathy in an Irish Population and Assessment for Prognostic Biomarkers.

Authors:  Kirk A J Stephenson; Joseph McAndrew; Paul F Kenna; Lorraine Cassidy
Journal:  Neuroophthalmology       Date:  2022-03-02

4.  Genetic and Clinical Analyses of DOA and LHON in 304 Chinese Patients with Suspected Childhood-Onset Hereditary Optic Neuropathy.

Authors:  Yadi Li; Jie Li; Xiaoyun Jia; Xueshan Xiao; Shiqiang Li; Xiangming Guo
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

Review 5.  Current and Emerging Treatment Modalities for Leber's Hereditary Optic Neuropathy: A Review of the Literature.

Authors:  Anna Theodorou-Kanakari; Spyridon Karampitianis; Vasiliki Karageorgou; Eleni Kampourelli; Efstathios Kapasakis; Panagiotis Theodossiadis; Irini Chatziralli
Journal:  Adv Ther       Date:  2018-09-01       Impact factor: 3.845

Review 6.  Molecular Biomarkers in Multiple Sclerosis and Its Related Disorders: A Critical Review.

Authors:  Maryam Gul; Amirhossein Azari Jafari; Muffaqam Shah; Seyyedmohammadsadeq Mirmoeeni; Safee Ullah Haider; Sadia Moinuddin; Ammar Chaudhry
Journal:  Int J Mol Sci       Date:  2020-08-21       Impact factor: 5.923

Review 7.  Mitochondrial Dynamics: Molecular Mechanisms, Related Primary Mitochondrial Disorders and Therapeutic Approaches.

Authors:  Michela Di Nottia; Daniela Verrigni; Alessandra Torraco; Teresa Rizza; Enrico Bertini; Rosalba Carrozzo
Journal:  Genes (Basel)       Date:  2021-02-10       Impact factor: 4.096

8.  Gene therapy restores mitochondrial function and protects retinal ganglion cells in optic neuropathy induced by a mito-targeted mutant ND1 gene.

Authors:  Yuan Liu; Jeremy D Eastwood; Diego E Alba; Sindhu Velmurugan; Ning Sun; Vittorio Porciatti; Richard K Lee; William W Hauswirth; John Guy; Hong Yu
Journal:  Gene Ther       Date:  2022-04-06       Impact factor: 4.184

9.  OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.

Authors:  Emmanuelle Sarzi; Marie Seveno; Camille Piro-Mégy; Lucie Elzière; Mélanie Quilès; Marie Péquignot; Agnès Müller; Christian P Hamel; Guy Lenaers; Cécile Delettre
Journal:  Sci Rep       Date:  2018-02-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.